Cynthia L. Lucchese, an insider at Cooper Companies Inc (COO), purchased 9,445 shares of the company's stock at a price of $84.06 per share on December 21, 2025. The total value of this transaction amounted to approximately $794,000. Following this purchase, Lucchese holds a total of 9,445 shares in Cooper Companies.
This transaction adds to the ongoing scrutiny of insider trading activity within the health care sector, where Cooper Companies operates as a medical device company. Headquartered in San Ramon, California, the firm employs around 16,000 people and is divided into two main business units: CooperVision, which focuses on the contact lens market, and CooperSurgical, which addresses fertility and women's health care.
The company's recent financial snapshot indicates a market capitalization of $14.2 billion, a price-to-earnings (P/E) ratio of 34.78, and earnings per share (EPS) of 2.03. Additionally, Cooper Companies offers a dividend yield of 1.8%. Upcoming earnings are anticipated on May 27, 2026, with an estimated EPS of $1.08 and revenue of $1.1 billion.
Insider transactions, such as Lucchese's purchase, provide insight into the confidence executives have in their company's performance. However, these activities should be considered alongside broader market conditions and other financial indicators. Investors are advised to analyse patterns of insider trading over time rather than relying on individual transactions for decision-making.